Clinical studies using animal models have widely demonstrated the importance of Aβ, a 4-kDa peptide derived from the sequential proteolytic cleavage of the amyloid precursor protein (APP) by β- and γ-secretase, in the progression of AD. Here, APP is linked to Alzheimer disease.